PLX
#3639
Protalix BioTherapeutics, Inc. Common Stock
2.3 7 USD
+0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+2.60%
Monthly Change
+2.16%
6 month change
-18.84%
Year Change
-18.84%
Previous Close
2.3 1
Open
2.3 6
Low
2.3 5
High
2.3 9
Volume
176
Financials
2020
Current report, Q4 FY2020
Protalix Biotherapeutics, Inc. current report, Q4 FY2020
8-K
Current report, Q4 FY2020
Protalix Biotherapeutics, Inc. current report, Q4 FY2020
8-K
Current report, Q3 FY2020
Protalix Biotherapeutics, Inc. current report, Q3 FY2020
8-K
Current report, Q3 FY2020
Protalix Biotherapeutics, Inc. current report, Q3 FY2020
8-K
Current report, Q3 FY2020
Protalix Biotherapeutics, Inc. current report, Q3 FY2020
8-K
Current report, Q2 FY2020
Protalix Biotherapeutics, Inc. current report, Q2 FY2020
8-K
Current report, Q2 FY2020
Protalix Biotherapeutics, Inc. current report, Q2 FY2020
8-K
Current report, Q2 FY2020
Protalix Biotherapeutics, Inc. current report, Q2 FY2020
8-K
Current report, Q2 FY2020
Protalix Biotherapeutics, Inc. current report, Q2 FY2020
8-K
Current report, Q2 FY2020
Protalix Biotherapeutics, Inc. current report, Q2 FY2020
8-K